Artiva Biotherapeutics, Inc.ARTVNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank50
3Y CAGR-17.0%
5Y CAGR+2.9%
Year-over-Year Change
Debt-to-assets ratio
3Y CAGR
-17.0%/yr
Annual compound
5Y CAGR
+2.9%/yr
Recent deceleration
Percentile
P50
Within normal range
vs 5Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.08 | +22.0% |
| 2024 | 0.07 | -57.4% |
| 2023 | 0.16 | +10.1% |
| 2022 | 0.15 | +1326.6% |
| 2021 | 0.01 | -85.8% |
| 2020 | 0.07 | -95.5% |
| 2019 | 1.62 | - |